93 algorithm-development-"Multiple"-"Simons-Foundation"-"Embry-Riddle-Aeronautical-University" "Prof" positions at University of Leeds
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
are seeking a motivated Assistant Research Software Engineer who is eager to support world-class research through software development, data handling, high-performance computation, advocacy for reproducibility
-
support of services that underpin a range of business critical activities and projects for our Digital Education Service as we undertake an 18 month change programme. This will focus on developing and
-
venue. To realise this ambition, we seek to appoint a Business Development Manager who can proactively support the development, implementation and delivery of an ambitious sales strategy to grow and
-
Mamatha Nagaraj, Prof Helen Gleeson, Prof Gordon Love, and Dr Richard Mandle and at the University of Leeds. You will have an experimental PhD degree (or have submitted your thesis before taking up the role
-
Mamatha Nagaraj , Prof Helen Gleeson , Prof Gordon Love , and Dr Richard Mandle and at the University of Leeds. You will have an PhD degree (or have submitted your thesis before taking up the role) and
-
? Do you want to develop your career in one of the UK’s leading research-intensive Universities? We are looking for an enthusiastic and agile post-doctoral Research Fellow to work on the Healthy Low
-
Multiple Sclerosis (MS) with a view to highlighting the implications for clinical practice. A recently completed PhD (PhD1) study, supervised by Dr Andrea Hollomotz and Professor Helen Ford at the University
-
decision making, while you will be capable to apply machine learning and computational algorithms of social choice. This post is associated with following projects: Embedding EDI in the Distribution
-
may include multiple finance workstreams including for example; Quote to Cash, Acquire to Retire, Transact to Record, Record to Report, Project to Result. Much of the work is expected to focus
-
inflammation in multiple organs, type I interferon activity autoantibodies poor quality of life. Musculoskeletal manifestations are among the most common and impactful to patients but poorly treated. We have